Aveanna Healthcare Holdings Inc. reported Q3 2026 revenue of $695.5 million, up 11.8%, gross margin of 32.6% and Adjusted EBITDA of $100.1 million. YTD free cash flow reached $141.2 million, and liquidity totaled $492.1 million.
AVAH · Aveanna Healthcare Holdings, Inc. · Documents
$11.50
-0.74 (-6.05%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$2.51B
Shares
218.41M
Volume · Nov 13
4.27M
Avg daily vol (3M)
3.01M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2026
Nov 13
Current report
8-K
Q3 revenue rises 11.8%; Adjusted EBITDA reaches $100.1 million
Nov 12
Quarterly report
10-Q
FY2026 Q3, ended Oct 3
Quarterly report for FY2026 Q3
AI summary on its way
Revenue $695.54M
▲ 11.8%
Net income $45.45M
▲ 223.2%
Diluted EPS $0.20
▲ 233.3%
Nov 12
Oct 2
Current report
8-K
Events of Oct 1
Director or officer change, or executive pay
On October 1, 2026, Steven E. Rodgers resigned effective immediately from Aveanna Healthcare Holdings Inc.’s Board of Directors, citing no disagreement with the company over its operations, policies, or practices; he served on the Audit and Compensation Committees.
Sep 16
Sep 15
Aug 24
Aug 13
Aug 13
Aug 13
Aug 13
Quarterly report
10-Q
FY2026 Q2, ended Jul 4
Quarterly report for FY2026 Q2
AI summary on its way
Revenue $670.48M
▲ 13.7%
Net income $40.29M
▲ 49.1%
Diluted EPS $0.18
▲ 38.5%
Aug 7
Current report
8-K
Events of Aug 5
Director or officer change, or executive pay
AI summary on its way
Jun 2
Jun 2
May 29
May 28
May 15
May 14
May 14
May 14
Quarterly report
10-Q
FY2026 Q1, ended Apr 4
Quarterly report for FY2026 Q1
AI summary on its way
Revenue $647.92M
▲ 15.9%
Net income $41.65M
▲ 702.1%
Diluted EPS $0.19
▲ 533.3%
Apr 17
Apr 17
Apr 17
Mar 20
Mar 19
Mar 19
Annual report
10-K
FY2025, ended Jan 3
Annual report for FY2025
AI summary on its way
Revenue $2.43B
▲ 20.2%
Net income $225.03M
Diluted EPS $1.05
Mar 12
Feb 27
Feb 20
Current report
8-K
Events of Feb 17
Director or officer change, or executive pay
AI summary on its way
Jan 14
2025
Nov 14
Current report
8-K
Events of Nov 13
Entered into a material agreement, Director or officer change, or executive pay
Nov 7
Current report
8-K
Regulation FD disclosure
Nov 6
Earnings call
Q3 2025 earnings call
Nov 6
Current report
8-K
Financial results, Regulation FD disclosure
Nov 6
Quarterly report
10-Q
FY2025 Q3, ended Sep 27
Quarterly report for FY2025 Q3
Revenue $621.94M
▲ 22.2%
Net income $14.06M
Diluted EPS $0.06
Oct 23
Current report
8-K
Other events
Oct 21
Current report
8-K
Financial results
Sep 29
Current report
8-K
Regulation FD disclosure
Sep 18
Current report
8-K
Events of Sep 17
Entered into a material agreement, Ended a material agreement, New debt or off-balance-sheet obligation, Other events
Aug 11
Quarterly report
10-Q/A
Ended Jun 28
Quarterly report for the period ended Jun 28, 2025
Aug 8
Current report
8-K
Regulation FD disclosure
Aug 7
Earnings call
Q2 2025 earnings call
Aug 7
Current report
8-K
Financial results, Regulation FD disclosure
Aug 7
Quarterly report
10-Q
FY2025 Q2, ended Jun 28
Quarterly report for FY2025 Q2
Revenue $589.55M
▲ 16.8%
Net income $27.03M
▲ 94.3%
Diluted EPS $0.13
▲ 85.7%
Jun 27
Current report
8-K
Events of Jun 25
Entered into a material agreement
Jun 4
Current report
8-K/A
Events of Apr 1
Unregistered sale of equity
May 9
Current report
8-K
Regulation FD disclosure
May 9
Current report
8-K
Shareholder vote results
May 8
Earnings call
Q1 2025 earnings call
May 8
Current report
8-K
Financial results, Regulation FD disclosure
Showing 1–50 of 151 documents
Key facts
CIK
1832332
CUSIP
05356F105
13F (30d)
187 filings
172 filers
Visit website
Investor relations